HUE055882T2 - Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére - Google Patents

Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére

Info

Publication number
HUE055882T2
HUE055882T2 HUE17727376A HUE17727376A HUE055882T2 HU E055882 T2 HUE055882 T2 HU E055882T2 HU E17727376 A HUE17727376 A HU E17727376A HU E17727376 A HUE17727376 A HU E17727376A HU E055882 T2 HUE055882 T2 HU E055882T2
Authority
HU
Hungary
Prior art keywords
compositions
metabolic disorders
polycystic ovary
ovary syndrome
related metabolic
Prior art date
Application number
HUE17727376A
Other languages
English (en)
Inventor
Bernard Fioretti
Lucio Leonardi
Original Assignee
S&R Farm S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56555565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE055882(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by S&R Farm S P A filed Critical S&R Farm S P A
Publication of HUE055882T2 publication Critical patent/HUE055882T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HUE17727376A 2016-04-13 2017-04-13 Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére HUE055882T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002575A ITUA20162575A1 (it) 2016-04-13 2016-04-13 Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa

Publications (1)

Publication Number Publication Date
HUE055882T2 true HUE055882T2 (hu) 2021-12-28

Family

ID=56555565

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17727376A HUE055882T2 (hu) 2016-04-13 2017-04-13 Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére

Country Status (7)

Country Link
US (2) US11246834B2 (hu)
EP (1) EP3452012B1 (hu)
ES (1) ES2890050T3 (hu)
HU (1) HUE055882T2 (hu)
IT (1) ITUA20162575A1 (hu)
PL (1) PL3452012T3 (hu)
WO (1) WO2017179012A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
BR112020010343A2 (pt) 2017-11-23 2020-11-10 Biosearch, S.A. método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
EP3810104B1 (en) * 2018-04-16 2024-03-06 S&R Farmaceutici S.p.A. Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility
IT201800011155A1 (it) * 2018-12-17 2020-06-17 S&R Farm S P A uso di una miscela di berberina e resveratrolo per il controllo delle dislipidemie
EP4000626A1 (en) * 2020-11-16 2022-05-25 concrete flowers GmbH Pharmaceutical preparation
WO2024127352A1 (en) * 2022-12-15 2024-06-20 Prolabin & Tefarm S.R.L. Formulation comprising vanilloid polyphenols supported on lamellar solids to reduce plasma cgrp levels and its applications

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040395A1 (it) 2004-08-03 2004-11-03 Sigma Tau Ind Farmaceuti Composizione comprendente statine e acidi grassi omega 3.
US20100129467A9 (en) 2007-08-31 2010-05-27 Albritton Iv Ford D Nutritional supplement
US8383165B1 (en) 2009-08-31 2013-02-26 Fairhaven Health, Llc Composition and method for fertility therapy using nutritional supplements
IT1404171B1 (it) * 2011-02-10 2013-11-15 Paladin Pharma S P A Composizione per l'uso nel trattamento dei problemi/disturbi della menopausa e nel trattamento dell'invecchiamento generale dell'organismo
US20130224281A1 (en) 2011-04-07 2013-08-29 United States Of America As Represented By The Administrator Of The National Aeronautics & Space Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress
ITFI20110252A1 (it) * 2011-11-22 2013-05-23 Lo Li Pharma Srl Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
ITPG20120030A1 (it) 2012-06-27 2013-12-29 Bernard Fioretti Resveratrolo inorganico ibrido
ITRM20130655A1 (it) * 2013-11-26 2015-05-27 Dicofarm Spa Prodotto a base di una associazione di glucomannano ed inositolo
IN2014MU01312A (hu) * 2014-04-09 2015-10-16 Olive Healthcare
ITUB20153066A1 (it) 2015-08-11 2017-02-11 Graal S R L Composizione alimentare e/o nutraceutica contenente pea
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
US10092545B2 (en) 2016-04-30 2018-10-09 Fairhaven Health, Llc Nutritional supplements for improving female fertility
EP3810104B1 (en) 2018-04-16 2024-03-06 S&R Farmaceutici S.p.A. Mixture of resveratrol supported on magnesium hydroxide and non-supported pure resveratrol for treating female fertility

Also Published As

Publication number Publication date
US20220395460A1 (en) 2022-12-15
ITUA20162575A1 (it) 2017-10-13
US20190125675A1 (en) 2019-05-02
PL3452012T3 (pl) 2022-01-24
WO2017179012A1 (en) 2017-10-19
US11246834B2 (en) 2022-02-15
EP3452012A1 (en) 2019-03-13
EP3452012B1 (en) 2021-06-23
ES2890050T3 (es) 2022-01-17

Similar Documents

Publication Publication Date Title
IL291533A (en) Compounds and preparations including them for the treatment of diseases of the central nervous system
IL275506A (en) Preparations and methods for the treatment of central nervous system disorders
EP3206493A4 (en) Compositions and methods for treating cns disorders
PT3250210T (pt) Composições e métodos para o tratamento de distúrbios do snc
EP3224269A4 (en) Compositions and methods for treating cns disorders
IL275562A (en) Preparations and methods for the treatment of central nervous system disorders
HUE055882T2 (hu) Készítmény policisztás ovárium szindróma és ehhez kapcsolódó anyagcserezavarok kezelésére
IL250715A0 (en) Preparations and methods for the treatment of cultural disorders
IL272061A (en) Preparations for the treatment of stress-related disorders
EP3280420A4 (en) Compositions and methods for treating cns disorders
IL264167A (en) Preparations and methods for the treatment of frontotemporal dementia
EP3142699A4 (en) Compositions and methods for treating metabolic disorders
HK1256298A1 (zh) 用於治療和預防神經退化性病症的組合物和方法
EP3442554A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES RELATED TO NEOVASCULARIZATION
EP3262065C0 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DYSTROGLYCANOPATHY DISEASES
EP3313387A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
PL3445362T3 (pl) Kompozycja i sposób leczenia zaburzeń metabolicznych
IL265255A (en) Dementia treatment preparations
PT3165229T (pt) Composição para a prevenção ou tratamento da síndrome do ovário policístico e seus sintomas relacionados
EP3687532A4 (en) COMPOSITIONS AND METHODS OF PREVENTION / TREATMENT OF METABOLIC SYNDROME